NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,133 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $404,548 | -0.4% | 3,800 | -9.5% | 0.01% | 0.0% |
Q1 2024 | $406,266 | -4.2% | 4,200 | 0.0% | 0.01% | -20.0% |
Q4 2023 | $424,074 | -0.9% | 4,200 | 0.0% | 0.01% | -9.1% |
Q3 2023 | $427,812 | +0.9% | 4,200 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $423,822 | +9.7% | 4,200 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $386,400 | -49.3% | 4,200 | -50.0% | 0.01% | 0.0% |
Q4 2022 | $762,048 | +138.9% | 8,400 | +100.0% | 0.01% | +10.0% |
Q3 2022 | $319,000 | -27.5% | 4,200 | -19.2% | 0.01% | -23.1% |
Q2 2022 | $440,000 | -3.5% | 5,200 | 0.0% | 0.01% | +18.2% |
Q1 2022 | $456,000 | +0.2% | 5,200 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $455,000 | +7.1% | 5,200 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $425,000 | -10.3% | 5,200 | 0.0% | 0.01% | -15.4% |
Q2 2021 | $474,000 | -2.7% | 5,200 | -8.8% | 0.01% | -13.3% |
Q1 2021 | $487,000 | -11.8% | 5,700 | -2.6% | 0.02% | -16.7% |
Q4 2020 | $552,000 | +7.8% | 5,850 | -0.6% | 0.02% | -5.3% |
Q3 2020 | $512,000 | -0.4% | 5,886 | 0.0% | 0.02% | 0.0% |
Q2 2020 | $514,000 | +27.5% | 5,886 | +20.5% | 0.02% | +5.6% |
Q1 2020 | $403,000 | -13.0% | 4,886 | 0.0% | 0.02% | +20.0% |
Q4 2019 | $463,000 | +7.4% | 4,886 | -1.5% | 0.02% | 0.0% |
Q3 2019 | $431,000 | -2.7% | 4,959 | +2.2% | 0.02% | -6.2% |
Q2 2019 | $443,000 | -46.1% | 4,850 | -43.3% | 0.02% | -44.8% |
Q1 2019 | $822,000 | +12.0% | 8,550 | 0.0% | 0.03% | 0.0% |
Q4 2018 | $734,000 | -0.4% | 8,550 | 0.0% | 0.03% | +26.1% |
Q3 2018 | $737,000 | +14.1% | 8,550 | 0.0% | 0.02% | +4.5% |
Q2 2018 | $646,000 | -6.5% | 8,550 | 0.0% | 0.02% | -4.3% |
Q1 2018 | $691,000 | -3.8% | 8,550 | 0.0% | 0.02% | -4.2% |
Q4 2017 | $718,000 | -11.2% | 8,550 | -9.3% | 0.02% | -11.1% |
Q3 2017 | $809,000 | +2.8% | 9,426 | 0.0% | 0.03% | +3.8% |
Q2 2017 | $787,000 | +12.4% | 9,426 | 0.0% | 0.03% | +8.3% |
Q1 2017 | $700,000 | -25.7% | 9,426 | -27.1% | 0.02% | -29.4% |
Q4 2016 | $942,000 | -27.4% | 12,926 | -21.3% | 0.03% | -27.7% |
Q3 2016 | $1,297,000 | -4.3% | 16,426 | 0.0% | 0.05% | -2.1% |
Q2 2016 | $1,355,000 | +13.9% | 16,426 | 0.0% | 0.05% | +14.3% |
Q1 2016 | $1,190,000 | -15.8% | 16,426 | 0.0% | 0.04% | -12.5% |
Q4 2015 | $1,413,000 | -41.9% | 16,426 | -37.9% | 0.05% | -35.1% |
Q3 2015 | $2,431,000 | -10.5% | 26,449 | -4.2% | 0.07% | +4.2% |
Q2 2015 | $2,715,000 | -0.9% | 27,599 | -0.7% | 0.07% | +2.9% |
Q1 2015 | $2,741,000 | +4.5% | 27,799 | -1.8% | 0.07% | +7.8% |
Q4 2014 | $2,623,000 | -1.5% | 28,299 | 0.0% | 0.06% | +1.6% |
Q3 2014 | $2,664,000 | +4.0% | 28,299 | 0.0% | 0.06% | +8.6% |
Q2 2014 | $2,562,000 | +5.9% | 28,299 | -0.5% | 0.06% | +1.8% |
Q1 2014 | $2,419,000 | +4.9% | 28,449 | -0.8% | 0.06% | +1.8% |
Q4 2013 | $2,305,000 | +4.8% | 28,679 | 0.0% | 0.06% | -3.4% |
Q3 2013 | $2,200,000 | +7.7% | 28,679 | -0.7% | 0.06% | +3.6% |
Q2 2013 | $2,042,000 | – | 28,879 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |